Related Experiment Video
Updated: Oct 28, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Heterotopic caval valve implantation in severe tricuspid regurgitation
Neeraj Kumar Sharma1, Nagendra Singh Chouhan2, Manish Bansal3
1Cardiac Anesthesia and Critical Care, Medanta-The Medicity, Gurugram, Haryana, India.
Abstract:
Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation III: Medical Management

